Navigation Links
Bausch + Lomb nomme Robert Bertolini président et directeur financier
Date:2/26/2013

ROCHESTER, New York, 26 février 2013 /PRNewswire/ -- Bausch + Lomb, société internationale spécialisée dans la santé oculaire, a nommé avec effet immédiat Robert Bertolini président et directeur financier. À ce poste, Robert Bertolini supervisera les fonctions liées à la finance, aux technologies de l'information ainsi qu'au contrôle de la qualité et aux opérations mondiales de la société. Robert Bertolini , qui prend la relève de Brian J. Harris à la direction financière, sera placé sous la responsabilité du directeur général de Bausch + Lomb, Brent Saunders .

(Logo : http://photos.prnewswire.com/prnh/20121221/MM34011LOGO )

« La vaste expérience de Robert Bertolini en matière de direction opérationnelle et transformatrice stratégique acquise en tant que directeur financier de l'une des plus grandes sociétés mondiales spécialisées dans les soins de santé cotées en bourse va permettre à Bausch + Lomb de tirer davantage parti de son potentiel et d'accélérer sa croissance », a déclaré M. Saunders. « J'ai eu l'occasion de travailler en étroite collaboration avec Robert Bertolini pendant de nombreuses années. Nous pouvons nous féliciter de voir un dirigeant de cette envergure rejoindre notre équipe à un moment aussi crucial de notre histoire. »  

La vaste expérience de M. Bertolini et sa connaissance approfondie des activités et stratégies d'entreprise ont toujours contribu&
'/>"/>

SOURCE Bausch + Lomb
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Bausch + Lomb Names John Barr Global President Surgical
2. Bausch + Lomb Completes the Acquisition of ISTA Pharmaceuticals
3. Bausch + Lomb Commences Tender Offer of Its 9 7/8% Senior Notes due 2015 (CUSIP Nos. 071707AN3 and U07190AA6)
4. Bausch + Lomb Announces Extension of Early Tender Date for Its Previously Announced Tender Offer for Its 9 7/8% Senior Notes due 2015 (CUSIP Nos. 071707AN3, U07190AA6 and 071707AP8)
5. Bausch + Lomb Announces Final Results for Its Previously Announced Tender Offer for Its 9 7/8% Senior Notes due 2015 (CUSIP Nos. 071707AN3, U07190AA6 and 071707AP8)
6. Bausch + Lomb Product, Platform and Pipeline Innovations on Display at the Annual Meeting of the American Academy of Ophthalmology
7. Bausch + Lomb und CROMA spenden dringend benötigte Augentropfen
8. Bausch + Lomb Names Robert Bertolini President And Chief Financial Officer
9. ReShape Medical Appoints Robert E. Grant to Board of Directors
10. ARAMARK Healthcare Technologies Taps Robert Steele to Lead ReMedPar
11. Lance Armstrong Update: Arrogant Even After Conceding Doping Charges, Asserts Former White House & WADA Spokesman Robert Weiner; Victory for Clean Sport but "Dark Message" Is Science Must Catch Up to Masking Agents Allowing Cheating
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Texas , Nov. 21, 2014  World Hemp ... containing low THC, announces they are now offering legal, ... to Charlotte,s Web type strains grown in medical marijuana ... other neurological disorders, such as Parkinson,s, MS, and spinal ... US laws to pass, because imported CBD Oil Is ...
(Date:11/21/2014)... , 21. November 2014 /PRNewswire/ ... hat heute bekannt gegeben, dass die ... EMA) die Kennzeichnung als Orphan-Medizinprodukt an ... des Unternehmens zur Behandlung von Fibrodysplasia ... seltene, stark beeinträchtigende genetische Krankheit, die ...
(Date:11/21/2014)... Nov. 20, 2014  Market research firm Kalorama information says ... The Buy, in the medical device industry.  The firm ... will produce just 3% growth this year, which led ... of product lines and entrance by acquisition into new ... medical devices, The Global Market for Medical Devices, ...
Breaking Medicine Technology:New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 3Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 2Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 3Kalorama: 2014 The "Year of The Buy" in Medical Device Industry 2
... HONG KONG, Feb. 25, 2011 /PRNewswire-Asia-FirstCall/ -- Golden ... - 801.HK; 910801.TW), China,s leading integrated healthcare enterprise, ... acquire the remaining interests in the Group,s Chinese ... HK$90 million in shares.  Upon completion of the ...
... Calif., Feb. 24, 2011 Amgen (Nasdaq: AMGN ... 3 head-to-head trial that compared XGEVA ™ (denosumab) to ... skeletal-related events (SREs) in 1,901 men with prostate cancer and ... met its primary and secondary endpoints and demonstrated XGEVA,s superiority ...
Cached Medicine Technology:Golden Meditech Acquires Remaining Stake in Chinese Herbal Medicine Business 2Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 2Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 3Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 4Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 5Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 6Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 7Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 8Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 9
(Date:11/22/2014)... NC (PRWEB) November 23, 2014 Cancer ... found a connection between intercellular communication tunnels and the ... read the full story on the Surviving Mesothelioma ... Center and the University of Minnesota have just released ... carry information and materials between cells. They found that ...
(Date:11/22/2014)... A classic black prom dress will never go ... suppliers, has unveiled its new items of black prom ... at a big discount, up to 70% off. People throughout ... new black prom dresses, made with the best materials, can ... of all customers, the company provides these beautiful outfits in ...
(Date:11/22/2014)... Today, Dylan Queen, a renowned brand in wedding ... the business offers a wide range of special occasion ... allowing them to create multiple looks easily. , According ... collection of chic wedding dresses has been prepared for ... discounted rates now. Dylan Queen can always create what ...
(Date:11/22/2014)... Discount-Dress.com is an important company in the dress industry. ... company’s online market share by a series of promotions. Recently, ... announced a bridesmaid dress promotion for the new year 2015. ... the dresses from this company are not only of high ... very good at manufacturing wedding dresses. Customers prefer to choose ...
(Date:11/22/2014)... "My friend went in for a mammogram ... said an inventor from Cambria Heights, N.Y. "To add ... second time because the first results were inaccurate. Her ... patent-pending MAMO EASY to offer a more comfortable way ... patient from the pain normally involved with this procedure. ...
Breaking Medicine News(10 mins):Health News:Study Links Cellular ‘Tunnels’ to Mesothelioma Proliferation, According to Surviving Mesothelioma 2Health News:New Black Prom Dresses from BellasDress.com 2Health News:Dylan Queen Introduces Its New Wedding Dresses 2Health News:Bridesmaid Dresses Introduced by Famous Company Discount-Dress.com For The New Year 2015 2
... Storage and to Advance VSEL Research, NEW YORK, ... is pioneering the pre-disease collection, processing and long-term,storage of ... that,it has signed a collection center agreement with the ... Robin Smith, MD MBA, NeoStem,s Chairman and Chief Executive ...
... May 27 Isis,Pharmaceuticals, Inc. (Nasdaq: ISIS ... dollars from Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY ... the recently announced transaction,between Takeda Pharmaceutical Company Limited ... receive portions of future milestone and royalty,payments. This ...
... communities save time and money accepting automatic ... payments direct from resident bank accounts, PORTLAND, ... it,has added PaySimple, the leading provider of on-demand ... to help simplify resident billing,and collection for assisted ...
... join the Urban League of,Philadelphia for FREE Open House Clinics ... ages 19 and under, in,Pennsylvania,s Children,s Health Insurance Program (CHIP). ... the Urban League of Philadelphia, 121,S. Broad Street (between Chestnut ... Wednesday, May 28th, 6pm - 8pm Wednesday, ...
... at UCLA have identified a type of leukemia stem cell ... normal blood stem cells to become cancerous. , The discovery ... cells, attacking the disease at its very root and killing ... cells. The study appears in the May 22, 2008 issue ...
... Inc. (Nasdaq: EVVV ) today,announced that Robert Palmisano, ... the Goldman Sachs Twenty-Ninth Annual Global,Healthcare Conference on Tuesday, ... and 1:00 p.m. CT). The Goldman Sachs Twenty-Ninth Annual ... Niguel in,Dana Point, California., To access the webcast, ...
Cached Medicine News:Health News:NeoStem Signs Stem Cell Collection Agreement With University of Louisville Hospital 2Health News:NeoStem Signs Stem Cell Collection Agreement With University of Louisville Hospital 3Health News:Isis to Receive $4.6 Million From Alnylam 2Health News:Isis to Receive $4.6 Million From Alnylam 3Health News:Vigilan Offers PaySimple to Simplify Resident Billing and Collection 2Health News:Does Your Child Have Health Insurance? Urban League of Philadelphia Announces Free Open Houses for CHIP Enrollment 2Health News:UCLA researchers identify leukemia stem cells 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: